Delivery Order SPE2DB22D1017-SPE2DB25FF6GE
Award Date
2/25/25
Potential Completion Date
2/26/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $12,650.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order for the supply of Repaglinide 1 mg tablets, which are used to treat diabetes. The contract has an Ultimate Completion Date of February 5, 2024 and was awarded on February 2, 2024 under a Firm Fixed Price pricing type. This contract award is not designated with any set-aside...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of repaglinide 1 mg tablets. The $2,763.86 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has an ultimate completion date of February 1, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of Repaglinide 1 mg tablets to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $7,964.57, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 1, 2024 and is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds significant Indefinite...
This federal contract award, identified as SPE2DB24D1034|SPE2DB25FWAQ2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567321287 units of 1 mg Repaglinide tablets, a medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,628.82 and a period of performance through February 21, 2025. This award...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Repaglinide 1 mg tablets, a medication used to manage diabetes, with a ceiling value of $13,095.99 and a period of performance through May 6, 2024. The contract was awarded as a Firm Fixed Price Delivery Order and was not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
The federal contract award is for the delivery of 100 tablets of the pharmaceutical drug Repaglinide 1 mg. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price of $1,609.80 and a period of performance through February 5, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $61,200 to Amerisourcebergen Drug Corporation for the supply of 100 units of 0.5 mg Repaglinide tablets. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The single day order from August 7-8, 2023 is being fulfilled under an existing indefinite-delivery/indefinite-quantity contract vehicle with the DLA, though further details regarding the base IDIQ are not provided....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,746.24 firm fixed-price delivery order is for 4565483693 NATEGLINIDE 120 MG TABLET UD 30S, with an ultimate completion date of August 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $8,876.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,012.68 firm-fixed-price delivery order is for the supply of 4565699628 Nateglinide 120 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of September 6, 2024. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...